![]() |
市场调查报告书
商品编码
1800974
2025 年至 2033 年蒸汽高压灭菌器市场报告(按配置、技术、应用和地区)Steam Autoclaves Market Report by Configuration, Technology, Application, and Region 2025-2033 |
2024年,全球蒸气高压灭菌器市场规模达29亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到54亿美元,2025-2033年期间的复合年增长率(CAGR)为6.91%。对感染控制的日益重视、製药和生命科学领域研发活动的不断拓展、门诊医疗保健的兴起以及对紧凑型台式高压灭菌器的需求,是推动市场增长的一些主要因素。
日益重视感染控制和病人安全
该行业的主要驱动力之一是人们日益重视医疗环境中的感染控制和病人安全。医院内感染 (HAI) 对病人安全构成重大威胁,并可能导致发病率、死亡率和医疗成本的增加。例如,根据美国食品药物管理局 (FDA) 发表的一篇文章,由医疗器材引起的医院内感染 (HCAI) 不仅危及患者的健康和生命,还会给患者和医疗保健系统带来额外的经济负担。感染可能由多种因素引起,包括可重复使用医疗器械的清洁、消毒和灭菌不当、植入后细菌粘附在器械上以及外部通讯设备造成的皮肤破损。蒸汽高压灭菌器在医疗器材、设备和用品的灭菌过程中发挥关键作用,可防止病原体传播并降低医院内感染 (HAI) 风险,从而有助于提升蒸汽高压灭菌器的市场份额。同时,随着医疗保健提供者努力降低感染风险并提高患者护理质量,对可靠且高效的灭菌解决方案的需求也日益增长。例如,根据美国食品药物管理局 (FDA) 2023 年 1 月发表的一篇文章,FDA 的无菌和感染控制计画在设备和放射健康中心 (CDRH) 进行监管科学研究,以帮助确保患者能够获得安全、功能齐全且无微生物和生化污染的医疗器材。这些因素对蒸汽高压灭菌器市场预测产生了积极影响。
扩大研发活动
在不断加大的研发投入的推动下,製药、生技和生命科学产业正在经历强劲成长。这些产业高度依赖实验室设备和材料的无菌性来维护实验的完整性并确保产品的安全性和有效性。例如,LTE Scientific 于 2024 年 3 月推出了最新产品系列 Touchclave-V 系列实验室高压灭菌器。 Touchclave-V 系列提供了一种低成本解决方案,可满足大多数实验室应用的需求。 Touchclave-V 系列是一款顶部装载的圆柱形腔室高压灭菌器,容量为 50 公升和 80 公升,设计简洁。这进一步对蒸汽高压灭菌器市场的近期价格产生了积极影响。此外,不断成长的研发投入也推动了对能够可靠且有效率地对这些物品进行灭菌的高压灭菌器的需求。随着科学进步和创新发现推动这些行业的进一步成长,这一趋势可能会持续下去。例如,2024年5月,生技公司Nucleome Therapeutics购买了一台LTE研究级高压灭菌器,用于辅助研究。 Nucleome Therapeutics专注于解码暗基因组的非编码DNA区域,以开发多发性硬化症、红斑性狼疮和类风湿性关节炎等自体免疫疾病的精准疗法。这些因素进一步提振了蒸汽高压灭菌器市场的收入。
技术进步
蒸汽高压灭菌器的技术进步提高了灭菌过程的效率。增强的循环控制、自动化功能以及最佳化的加热和冷却机制有助于缩短循环时间并提高处理量,使医疗机构能够更快、更有效地对器械和设备进行灭菌。例如,2024年3月,Syntegon的子公司Schoeller-Bleckmann Medizintechnik (SBM)推出了全新灭菌器系列SBM Essential Line。 SBM Essential Line的灭菌器采用真空蒸气(ADV)、蒸气空气混合(SDR)或组合(SDT)程序,可对多孔和固体设备以及西林瓶、卡式瓶或註射笔等容器中的液体进行消毒。此外,该系列还配备风扇、夹套冷却和内部热交换器,可在灭菌后快速冷却。此外,製造商也不断创新,开发出循环时间更短且灭菌效果更佳的蒸气高压灭菌器。先进的加热和冷却机制、优化的循环演算法以及快速排气系统使高性能高压灭菌器能够更快地对器械进行灭菌,从而提高医疗机构的工作流程效率和处理量。例如,2024年5月,全球技术、营运咨询和专案管理服务供应商CAI与高性能灭菌系统生产商和服务供应商Fedegari集团达成合作。该协议将提升生命科学和生物技术产业企业的蒸气灭菌能力。此次合作旨在改善蒸汽灭菌科学的应用,同时缩短灭菌流程的安装时间,从而降低全生命週期成本、削减产品成本并简化製造流程。这些因素正在提升蒸气高压灭菌器的市场占有率。
The global steam autoclaves market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.91% during 2025-2033. The growing emphasis on infection control, expanding R&D activities in pharmaceuticals and life sciences, the rise of ambulatory healthcare, and demand for compact tabletop autoclaves, are some of the major factors propelling the market growth.
Surging Emphasis on Infection Control and Patient Safety
One of the primary drivers of the industry is the increasing focus on infection control and patient safety within healthcare settings. HAIs pose a significant threat to patient safety and can lead to increased morbidity, mortality, and healthcare costs. For instance, according to an article published by the U.S. Food and Drug Administration, healthcare-associated infections (HCAIs) caused by medical devices not only risk patients' health and lives but also place an additional financial burden on patients and the healthcare system. Infections can arise as a result of a variety of factors, including poor cleaning, disinfection, and sterilization of reusable medical devices, bacterial adhesion to devices after implantation, and skin breaches caused by external communication devices. Steam autoclaves play a critical role in sterilizing medical instruments, equipment, and supplies to prevent the transmission of pathogens and reduce the risk of HAIs, thereby contributing to the steam autoclaves market share. In confluence with this, as healthcare providers strive to reduce the risk of infections and improve the quality of patient care, there is a growing demand for reliable and efficient sterilization solutions. For instance, according to an article published by the U.S. Food and Drug Administration in January 2023, regulatory science research is carried out by the FDA's Sterility and Infection Control Program at the Center for Devices and Radiological Health (CDRH) to help guarantee that patients have access to safe and functional medical devices that are devoid of microbiological and biochemical contamination. These factors are positively influencing the steam autoclaves market forecast.
Expanding Research and Development Activities
The pharmaceutical, biotechnology, and life sciences industries are experiencing robust growth, driven by the increasing research and development (R&D) efforts. These industries heavily rely on the sterility of laboratory equipment and materials to maintain the integrity of experiments and ensure the safety and efficacy of products. For instance, in March 2024, LTE Scientific launched its newest line, the Touchclave-V series of laboratory autoclaves. The Touchclave-V series provides a low-cost solution that can handle the majority of laboratory applications. The Touchclave-V series is a top-loading cylindrical chambered autoclave with capacities of 50 and 80 liters, designed for simplicity. This is further positively impacting the steam autoclaves market's recent price. Apart from this, growing investments in research and development (R&D) are propelling the demand for autoclaves that can reliably and efficiently sterilize these items. This trend is likely to persist as scientific advancements and innovative discoveries drive further growth in these sectors. For instance, in May 2024, Nucleome Therapeutics, a biotech company that specializes in decoding the dark genome's non-coding DNA regions to produce precision treatments for autoimmune disorders such as multiple sclerosis, lupus, and rheumatoid arthritis, purchased an LTE research-grade autoclave to aid in research. These factors are further bolstering the steam autoclaves market revenue.
Technological Advancements
Technological advancements in steam autoclaves have led to increased efficiency in sterilization processes. Enhanced cycle controls, automation features, and optimized heating and cooling mechanisms contribute to shorter cycle times and higher throughput, allowing healthcare facilities to sterilize instruments and equipment more quickly and effectively. For instance, in March 2024, Schoeller-Bleckmann Medizintechnik (SBM), a Syntegon subsidiary, launched the SBM Essential Line, a new range of sterilizers. The SBM Essential Line's sterilizers disinfect porous and solid equipment, as well as liquids in containers such as vials, cartridges, or pens, using either a vacuum-steam (ADV), steam-air mixture (SDR), or combined (SDT) procedure. Fans, jacket cooling, and internal heat exchangers are offered for quick cooling following sterilization. Apart from this, manufacturers are continually innovating to develop steam autoclaves with shorter cycle times without compromising sterilization efficacy. Advanced heating and cooling mechanisms, optimized cycle algorithms, and rapid exhaust systems enable high-performance autoclaves to sterilize instruments more quickly, improving workflow efficiency and throughput in healthcare facilities. For instance, in May 2024, CAI, a global provider of technical, operational consulting, and project management services, collaborated with Fedegari Group, a producer and service provider of high-performance sterilization systems. This agreement will improve steam sterilization capabilities for firms in the life sciences and biotech industries. The partnership's purpose is to improve the application of steam sterilization science while reducing sterilization process installation time in order to reduce lifetime costs, slash product costs, and streamline manufacturing processes. These factors are contributing to the steam autoclaves market share.
Table top steam autoclaves dominate the market
According to the steam autoclaves outlook, the increasing prevalence of smaller healthcare facilities, including dental clinics, veterinary practices, and smaller outpatient centers, is fueling the demand for compact and space-efficient sterilization solutions such as tabletop steam autoclaves. Tabletop autoclaves are ideal for such settings as they are compact, easy to install, and do not occupy valuable floor space. In addition to this, the rise of mobile healthcare units and field-based medical services, especially in remote or underserved areas, necessitates portable sterilization equipment. Tabletop autoclaves offer the mobility and flexibility required to ensure sterile conditions in these dynamic environments. Furthermore, their user-friendly interfaces and automated features make them accessible to a range of healthcare professionals, including those without extensive technical expertise. This accessibility factor further contributes to the growing demand for tabletop steam autoclaves across diverse healthcare and field-service applications.
Gravity displacement holds the largest share in the market
According to the steam autoclaves market overview, gravity displacement autoclaves are particularly well-suited for sterilizing delicate instruments, porous materials, and liquids that might be adversely affected by the vigorous air removal processes of pre-vacuum autoclaves. This gentler approach to air removal minimizes the risk of damaging sensitive items while still ensuring effective sterilization. In line with this, gravity displacement autoclaves are often more cost-effective than their pre-vacuum counterparts, making them a preferred choice for facilities with budget constraints, thereby aiding in market expansion. Moreover, their simplicity and ease of operation also appeal to a variety of industries, including dental clinics, small laboratories, and educational institutions, where specialized technical expertise may be limited. The demand for gravity displacement autoclaves continues to grow among users who prioritize efficient, yet gentle sterilization methods without compromising on effectiveness or affordability.
Medical represents the leading application segment
The demand for steam autoclaves in medical applications is primarily driven by the critical need for sterility and infection control within healthcare settings. In the medical field, maintaining aseptic conditions is paramount to prevent infections, safeguard patient well-being, and ensure successful surgical procedures. Steam autoclaves play a pivotal role in achieving these objectives by providing reliable and efficient sterilization of surgical instruments, medical devices, and equipment. With the global population aging and the healthcare industry continuously evolving, there is a growing number of medical facilities, including hospitals, clinics, and ambulatory surgery centers, all of which require sterilization solutions. Additionally, the increasing prevalence of outpatient care and the demand for rapid sterilization turnaround times, especially in emergency departments, drive the adoption of autoclaves tailored to the specific needs of these medical settings. Consequently, the demand for steam autoclaves in medical applications remains robust as healthcare providers prioritize patient safety and infection prevention. For instance, in December 2022, the Government of Mauritius, with the help of the Government of Japan, and the United Nations Development Program (UNDP) launched a new 500L autoclave at Victoria Hospital to commemorate the Ministry of Health and Wellness's cooperation with UNDP.
North America exhibits a clear dominance, accounting for the largest steam autoclaves market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the steam autoclaves market overview, North America's well-established healthcare infrastructure and the constant need for infection control measures in hospitals and medical facilities fuel the demand for sterilization equipment, including steam autoclaves. Besides this, the stringent regulatory standards and guidelines set by organizations such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) further emphasize the importance of maintaining sterile conditions, encouraging healthcare providers to invest in advanced autoclave technologies. Moreover, the rise in the prevalence of chronic illness and a rapidly aging population in North America result in higher demand for surgical procedures and medical interventions, boosting the need for reliable autoclaves in healthcare settings. In addition to this, the region's robust pharmaceutical and biotechnology industries, including vaccine production and research activities, drive the requirement for autoclaves for the sterilization of laboratory equipment and materials, thereby bolstering the market growth. Furthermore, the ongoing emphasis on research and development (R&D), coupled with technological advancements in steam autoclave design and functionality, is supporting the market growth. For instance, in February 2024, Dothan City Commissioners approved the group Daniels Sharpsmart to install autoclave in order to sterilize medical gauze, bandages, gowns, sharps, etc.
The market is characterized by intense competition among key players and a diverse range of manufacturers. Prominent companies dominate the market, leveraging their extensive product portfolios, established brand recognition, and global distribution networks. These industry leaders continuously invest in research and development to introduce innovative features like advanced sterilization cycles, user-friendly interfaces, and energy-efficient technologies, maintaining their competitive edge. Additionally, strategic mergers, acquisitions, and collaborations are common in the market, allowing companies to expand their product offerings and market reach. Price competitiveness and customization options have become vital for survival in this competitive landscape as customers seek cost-effective solutions tailored to their specific needs, creating a dynamic and evolving global steam autoclaves market.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: